Trans Genic Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3635720000
JPY
265.00
-7 (-2.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
3,470.38
3,026.92
3,197.94
3,197.44
3,495.81
3,429.17
2,882.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
3,470.38
3,026.92
3,197.94
3,197.44
3,495.81
3,429.17
2,882.71
Raw Material Cost
2,855.98
2,413.08
2,587.96
2,738.42
2,902.58
2,815.98
2,381.37
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.89
13.55
12.90
9.43
8.73
10.06
8.39
Selling and Distribution Expenses
581.24
587.70
564.71
592.45
608.14
618.22
602.82
Other Expenses
-0.99
-1.36
-1.29
-0.94
-0.87
-1.01
-0.84
Total Expenditure (Excl Depreciation)
3,437.22
3,000.78
3,152.67
3,330.87
3,510.72
3,434.19
2,984.19
Operating Profit (PBDIT) excl Other Income
33.199999999999996
26.099999999999998
45.300000000000004
-133.4
-14.9
-5
-101.5
Other Income
123.17
7.49
28.27
-15.73
16.67
-24.77
12.91
Operating Profit (PBDIT)
196.13
71.30
110.88
-97.56
50.73
16.39
-44.87
Interest
9.89
13.55
12.90
9.43
8.73
10.06
8.39
Exceptional Items
-128.84
-2.58
-21.58
-338.68
23.29
-31.80
-26.39
Gross Profit (PBDT)
614.39
613.84
609.98
459.02
593.23
613.19
501.35
Depreciation
39.81
37.67
37.34
51.61
48.98
46.19
43.70
Profit Before Tax
17.58
17.50
39.07
-497.27
16.31
-71.65
-123.35
Tax
18.83
15.51
30.31
295.73
128.82
14.18
-24.12
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-1.53
2.59
26.96
-797.98
-109.41
-82.83
-99.43
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-1.53
2.59
26.96
-797.98
-109.41
-82.83
-99.43
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.28
-0.61
-18.20
4.98
-3.10
-3.00
0.21
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-1.25
1.98
8.76
-793.00
-112.50
-85.83
-99.22
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,942.80
4,800.00
4,785.02
4,762.71
5,561.40
5,662.39
5,748.77
Earnings per share (EPS)
-0.09
0.16
1.62
-47.92
-6.57
-4.98
-5.99
Diluted Earnings per share
-0.09
0.16
1.62
-47.92
-6.57
-4.98
-5.99
Operating Profit Margin (Excl OI)
0.96%
0.86%
1.42%
-4.17%
-0.43%
-0.15%
-3.52%
Gross Profit Margin
1.65%
1.82%
2.39%
-13.94%
1.87%
-0.74%
-2.76%
PAT Margin
-0.04%
0.09%
0.84%
-24.96%
-3.13%
-2.42%
-3.45%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 14.65% vs -5.35% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -165.00% vs -77.27% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 14.42% vs -22.76% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -27.21% vs 5.43% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Trans Genic Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
3,470.38
1,742.60
1,727.78
99.15%
Other Operating Income
0.00
0.00
0.00
Total Operating income
3,470.38
1,742.60
1,727.78
99.15%
Raw Material Cost
2,855.98
1,405.37
1,450.61
103.22%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
9.89
10.19
-0.30
-2.94%
Selling and Distribution Expenses
581.24
185.85
395.39
212.75%
Other Expenses
-0.99
27.25
-28.24
-103.63%
Total Expenditure (Excl Depreciation)
3,437.22
1,873.86
1,563.36
83.43%
Operating Profit (PBDIT) excl Other Income
33.15
-131.26
164.41
125.26%
Other Income
123.17
-70.14
193.31
275.61%
Operating Profit (PBDIT)
196.13
-201.34
397.47
197.41%
Interest
9.89
10.19
-0.30
-2.94%
Exceptional Items
-128.84
0.00
-128.84
Gross Profit (PBDT)
614.39
337.24
277.15
82.18%
Depreciation
39.81
0.06
39.75
66,250.00%
Profit Before Tax
17.58
-211.59
229.17
108.31%
Tax
18.83
-8.21
27.04
329.35%
Provisions and contingencies
0
0
0.00
Profit After Tax
-1.53
-203.38
201.85
99.25%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-1.53
-203.38
201.85
99.25%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.28
0.00
0.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-1.25
-203.38
202.13
99.39%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,942.80
1,926.07
3,016.73
156.63%
Earnings per share (EPS)
-0.09
-4.10
4.01
97.80%
Diluted Earnings per share
-0.09
-4.10
4.01
97.80%
Operating Profit Margin (Excl OI)
0.96%
-7.53%
0.00
8.49%
Gross Profit Margin
1.65%
-12.14%
0.00
13.79%
PAT Margin
-0.04%
-11.67%
0.00
11.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 347.04 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.65% vs -5.35% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -0.73% vs 3.87% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit -0.13 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -165.00% vs -77.27% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 98.84% vs -32.51% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.30 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 14.42% vs -22.76% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 114.08% vs 1,000.00% in Dec 2024

Quarterly - Interest
Interest 0.99 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -27.21% vs 5.43% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 13.79% vs -24.35% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.96%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024